| PKM2, function and expression and regulation Z Zhang, X Deng, Y Liu, Y Liu, L Sun, F Chen Cell & bioscience 9, 1-25, 2019 | 365 | 2019 |
| Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review Y Liu, Z Zhang, J Wang, C Chen, X Tang, J Zhu, J Liu OncoTargets and therapy, 1195-1204, 2019 | 101 | 2019 |
| Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer Y Liu, C Li, Y Lu, C Liu, W Yang Frontiers in immunology 13, 1016817, 2022 | 91 | 2022 |
| Regulation mechanism of long noncoding RNAs in colon cancer development and progression X Tang, X Qiao, C Chen, Y Liu, J Zhu, J Liu Yonsei medical journal 60 (4), 319-325, 2019 | 54 | 2019 |
| Induction/reversal of drug resistance in gastric cancer by non-coding RNAs C Chen, X Tang, Y Liu, J Zhu, J Liu International journal of oncology 54 (5), 1511-1524, 2019 | 39 | 2019 |
| The role of metabolic reprogramming in pancreatic cancer chemoresistance C Liu, C Li, Y Liu Frontiers in Pharmacology 13, 1108776, 2023 | 20 | 2023 |
| Current understanding of circular RNAs in gastric cancer X Tang, J Zhu, Y Liu, C Chen, T Liu, J Liu Cancer Management and Research, 10509-10521, 2019 | 17 | 2019 |
| CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration J Liu, Z Tian, T Liu, D Wen, Z Ma, Y Liu, J Zhu Cell Cycle 20 (18), 1861-1874, 2021 | 7 | 2021 |
| Highly expressed IFITM10 is associated with early diagnosis and T stage of gastric cancer Y Liu, J Liu, Z Tian, Z Zhang, T Liu, C Chen, X Tang, J Zhu Translational Cancer Research 10 (1), 382, 2021 | 4 | 2021 |
